Author:
La Rosa Stefano,Sciarra Amedeo
Publisher
Springer International Publishing
Reference8 articles.
1. La Rosa, S., Franzi, F., Marchet, S., Finzi, G., Clerici, M., Vigetti, D., Chiaravalli, A. M., Sessa, F., & Capella, C. (2009). The monoclonal anti-BCL10 antibody (clone 331.1) is a sensitive and specific marker of pancreatic acinar cell carcinoma and pancreatic metaplasia. Virchows Archiv, 454, 133–142.
2. La Rosa, S., Adsay, V., Albarello, L., et al. (2012). Clinicopathologic study of 62 acinar cell carcinomas of the pancreas: Insights into the morphology and immunophenotype and search for prognostic markers. The American Journal of Surgical Pathology, 36, 1782–1795.
3. La Rosa, S., Sessa, F., & Capella, C. (2015). Acinar cell carcinoma of the pancreas: Overview of clinicopathologic features and insights into the molecular pathology. Frontiers in Medicine, 2, 41.
4. La Rosa, S., Klimstra, D. S., & Wood, L. D. (2019). Pancreatic acinar cell carcinoma. In WHO Classification of Tumours Editorial Board (Ed.), WHO classification of tumours (Digestive system tumours, 5th ed., pp. 333–336). IARC: Lyon.
5. Maragliano, R., Vanoli, A., Albarello, L., et al. (2015). ACTH-secreting pancreatic neoplasms associated with Cushing syndrome: Clinicopathologic study of 11 cases and review of the literature. The American Journal of Surgical Pathology, 39, 374–382.